期刊
JOURNAL OF PAEDIATRICS AND CHILD HEALTH
卷 50, 期 10, 页码 E68-E71出版社
WILEY
DOI: 10.1111/j.1440-1754.2010.01797.x
关键词
functional abdominal pain; functional gastrointestinal disorders (FGID); probiotics
类别
Aim: Functional abdominal pain (FAP) is a frequent condition affecting 10-20% of children and can be considered within the classification of functional gastrointestinal disorders (FGID). The objective of this study was to determine the effect of daily supplementation with the probiotic Lactobacillus reuteri DSM 17938 in children with FAP. Methods: The children (aged 6-16years) were screened for FAP as defined in the Rome III criteria and 60 patients were recruited in this double-blind, randomised, placebo-controlled trial. The children were randomly allocated to receive either L. reuteri (2x10(8)CFU/day) or identical placebo for 4weeks followed by a 4-week follow-up period without supplementation. Frequency and intensity of pain was self-recorded by the subjects. Results: The L. reuteri-supplemented children had significantly lower pain intensity compared with the placebo controls. Conclusions: Supplementation with L. reuteri reduced perceived abdominal pain intensity, which may encourage clinicians to use this probiotic in children with FAP.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据